In today’s Pharmaceutical Executive Daily, MJH Life Sciences CEO, Mike Hennessy Jr. examines why pharma and medtech still ...

The US Department of Health and Human Services (HHS) issued new guidance clarifying how pharmaceutical manufacturers can ...

Public Citizen filed a lawsuit against the Trump administration in the U.S. District Court for the District of Columbia ...

Tenpoint Therapeutics announced FDA’s approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% ...

A. Douglas Bender is an associate professor of management in the School of Business Management of Widener University, Chester, PA, where he teaches graduate courses in managed care organizations and ...

PE: After presenting topline results from Phase 3 trials, what's next for Varegacestat? Siegall: We presented topline data.

Gavi, the Vaccine Alliance, is a group that describes itself as being focused on improving access to vaccines for children living in the world’s poorest countries. While the United States previously ...

PE: What key learnings did your team learn during launch? Skalicky: Three things come to mind. First, integration beats ...

Lou Pillai is the founder of Ulivmo and most recently, he was the Head of Data and Digital at Immunomedics (acquired by Gilead). Ehsan Ehsani is a director of consulting at CGI and leader of ...

If you want the cleanest case study of pharma and diagnostics actually operating as one strategic engine, it’s Roche. Roche ...

In today’s Pharmaceutical Executive Daily, Insilico Medicine and Qilu Pharmaceuticals launch a $120 million collaboration to advance AI-driven cardiometabolic therapies, Eli Lilly enters a ...

FDA approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of adult patients with newly diagnosed multiple ...